This study identifies and characterizes a novel intronic splice-site variant (c.928+3A>G) in the LAMP2 gene that causes exon 7 skipping in 80% of transcripts, providing functional evidence to reclassify this variant from unknown significance to pathogenic for Danon disease.
Answers are grounded in this paper and cite their sources.
Novel LAMP2 splice variant expands known Danon spectrum; leaves open validation and prevalence in larger cohorts.
Background and Objectives: Danon disease is a multisystemic disorder associated with variants in the LAMP2 gene, mainly affecting the cardiac muscle. Here, we report a multigenerational family from Latvia with two male patients, hemizygous for a novel splice-affecting variant c.928+3A>G. Affected patients exhibit a cardiac phenotype, moderate mental disability, and mild retinal changes. Materials and Methods: Both patients underwent either exome or hypertrophic cardiomyopathy gene panel next-generation sequencing. The pathogenic variant effect was determined using reverse transcription, Sanger sequencing, and high-resolution electrophoresis. Results: Evaluation of the splicing process revealed that approximately 80% of the transcripts exhibited a lack of the entire exon 7. This alteration was predicted to cause a shift of the reading frame, consequently introducing a premature stop codon downstream in the sequence. Conclusions: Based on our data, we propose that c.928+3A>G is a pathogenic variant associated with Danon disease.
No takes yet. Share an insight, caveat, or question.
Stavusis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: